| Date Filed | Type | Description |
| 08/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/27/2023 |
4
| Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $38.6, valued at
$772k
Granted 5,000 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 750 shares
@ $0
Disposed/sold 750 restricted stock units
@ $0 |
|
| 02/21/2023 |
4
| Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Exercised 1,500 options to buy
@ $0 |
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/13/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/07/2012 |
4
| Martin Tami Tillotson (VP of Regulatory Affairs) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Bought 2,500 shares
@ $5, valued at
$12.5k
|
|
| 04/30/2012 |
3
| Martin Tami Tillotson (VP of Regulatory Affairs) has filed a Form 3 on SUPERNUS PHARMACEUTICALS INC |